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We have previously shown that 
maternal plasma copeptin (CPP), as a 
marker of vasopressin, is highly 
predictive of preeclampsia (PE) in the 
first trimester and remains elevated 
throughout pregnancy. Furthermore, in 
maternal urine samples we 
demonstrated that CPP was also 
significantly elevated in the first 
trimester in women who later developed 
PE. Because a urine dipstick test could 
be easily used in the clinic, we sought to 
validate this finding in a new and 
expanded cohort of samples and to 
determine whether these changes 
persist throughout pregnancy. In 
addition, to begin to address the 
mechanism for this difference, we also 
assessed urine osmolality to further 
probe renal function. In a case-control 
study (IRB# 2015038355), banked 
maternal urine samples and clinical data 
from each trimester from women who 
developed PE (N=117) and controls 
(N=593) were obtained from the 
University of Iowa Maternal Fetal Tissue 
Bank (MFTB) (IRB# 200910784). CPP 
concentrations were measured by 
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ELISA. Osmolality was determined by 
freezing point depression. Differences 
between groups were detected by Chi 
square, Student’s T Test, or ANOVA as 
appropriate. Using a validation cohort 
and a different ELISA (USCN vs 
Phoenix Pharmaceuticals), we validated 
our earlier findings. We again find a 
significant increase in the concentration 
of urine CPP in the first trimester in 
women who developed preeclampsia 
compared to women who did not (0.304 
± 0.03 vs 0.223 ± 0.01 pg/ml, P=0.03). 
No significant differences in copeptin 
were observed in urine CPP in the 2nd 
and 3rd trimesters from PE and control 
women (2nd tri: 0.205 ± 0.04 vs 0.213 ± 
0.02; 3rd tri: 0.290 ± 0.03 vs 0.336 ± 
0.02 pg/ml P>0.05 in 2nd and 3rd 
trimesters). In this cohort, we did not 
detect differences in urine osmolality 
between preeclamptics and controls in 
any trimester (1st tri: 606.09 ± 50.16 vs 
604.28 ± 16.72; 2nd tri 582.10 ± 36.30 
vs 596.96 ± 16.98; 3rd tri: 479.63 ± 
58.81 vs 583.75 ± 19.61 mOsm/kg 
H2O). We conclude that (i) PE is 
associated with increased maternal 
urinary CPP in the 1st trimester; (ii) this 
increase does not correlate with 
expected increases in urine osmolality. 
Future work will focus on understanding 
the mechanisms involved in the 
elevation in urinary CPP such as early 
immunologic changes or renal 
concentrating responses. 
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